KALARIS THERAPEUTICS, INC. Dividends, Cash
KALARIS THERAPEUTICS, INC. (KLRS) reported Dividends, Cash of $0 for the 2-month period ending 2025-03-18, per its 10-K filed 2026-03-17.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCash · last filed 2026-03-17
- KALARIS THERAPEUTICS, INC. dividends, cash for the quarter ending 2021-03-31 was $0.00.
- KALARIS THERAPEUTICS, INC. dividends, cash for the quarter ending 2020-12-31 was $0.00.
- KALARIS THERAPEUTICS, INC. dividends, cash for fiscal 2024 was $0.00.
- KALARIS THERAPEUTICS, INC. dividends, cash for fiscal 2023 was $0.00.
- KALARIS THERAPEUTICS, INC. dividends, cash for fiscal 2022 was $0.00.
- KALARIS THERAPEUTICS, INC. dividends, cash for fiscal 2021 was $0.00.
| Period end | Dividends, Cash 2 month | Dividends, Cash 3 month | Dividends, Cash 6 month | Dividends, Cash 9 month | Dividends, Cash 12 month |
|---|---|---|---|---|---|
| 2025-03-18 | $0.00 10-K · filed 2026-03-17 | ||||
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 | ||||
| 2023-12-31 | $0.00 10-K · filed 2024-03-15 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-02-15 | ||||
| 2021-12-31 | $0.00 10-K · filed 2022-02-10 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-05-06 | |||
| 2020-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2021-05-06 | $0.00 10-Q · filed 2021-05-06 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |